论文部分内容阅读
冠心病治疗措施尽管不断改进,但其病死率仍居高不下.研究发现心肌再灌注损伤是影响急性心肌梗死患者最终梗死面积的重要因素之一.有几种改善缺血再灌注损伤的药物及技术应用于试验模型及临床,但很多试验中很有前景的治疗措施在临床应用中却未显示出明显的益处.现就缺血后处理在急性ST抬高型心肌梗死患者中的应用做一综述.“,”Despite the improvement of treatment measures,coronary artery disease remains the leading cause of death in the world. Research has identified myocardial reperfusion injury as a significant contributor to the final infarct size in human patients.Several improved drugs and techniques have been applied at early reperfusion in experimental models and in the clinical setting.Numerous promising therapies in experimental models have failed to show significant benefits in clinical practice.This paper reviews the application of ischemic postcondi-tioning in patients with acute ST-segment elevation myocardial infarction.